Table 2.

Health state utility values and their plausibility ranges

Health state	Utility (base)	Plausibility range	Reference
Health states associated with prostate cancer
Postoperative recovery phase after radical prostatectomy	0.67	0.56–0.90a	Stewart et al. (25)
Delivery of radiation therapy	0.73	0.71–0.91a	Stewart et al. (25)
Adverse effects of definitive treatment
Erectile dysfunction	0.89	0.86–1.00a	Stewart et al. (25)
Urinary incontinence	0.83	0.78–0.98a	Stewart et al. (25)
Urinary incontinence and erectile dysfunction	0.79	0.76–0.96a	Stewart et al. (25)
Bowel dysfunction	0.71	0.61–0.90a	Stewart et al. (25)
Urinary incontinence and bowel dysfunction	0.70	0.66–0.88a	Stewart et al. (25)
Bowel dysfunction and erectile dysfunction	0.57	0.41–0.76a	Stewart et al. (25)
Urinary incontinence, erectile dysfunction, and bowel dysfunction	0.45	0.17–0.78a	Stewart et al. (25)
Biochemical recurrence	0.67	0.56–0.84a	Stewart et al. (25)
Symptomatic metastatic progression	0.25	0.01–0.52a	Stewart et al. (25)
Health states associated with kidney failure
Conservative management	0.900	0.700–1.000b	Hogan et al. (26)
Management by transplantation	0.775	0.675–0.875b	Hogan et al. (26)
Management by hemodialysis	0.525	0.450–0.600b	Hogan et al. (26)

In the event a patient experienced two or more health states at the same time (e.g., delivery of radiation therapy and conservative kidney failure management), the current health state utility value was always determined by the state with the lowest value.

^aInterquartile range.

^bRange used in sensitivity analyses of the reference study.